Mikael Kjær Poulsen

Medicine & Life Sciences

1. Heart Failure 100%
2. Aortic Valve Stenosis 92%
3. empagliflozin 92%
4. Type 2 Diabetes Mellitus 60%
5. Cardiovascular Diseases 48%
6. Aortic Valve 46%
7. Carotid Artery Diseases 33%
8. Osteoprotegerin 32%
9. Placebos 31%
10. Myocardial Ischemia 31%
11. Peripheral Arterial Disease 27%
12. Randomized Controlled Trials 27%
13. Left Ventricular Function 26%
14. fibulin 26%
15. SARS Virus 24%
16. Hemodynamics 23%
17. Hereditary Hemorrhagic Telangiectasia 23%
18. candesartan 23%
19. Transplant Recipients 23%
20. Ventricular Remodeling 22%
21. Vascular Malformations 20%
22. Stroke Volume 20%
23. Vaccines 18%
24. Atrial Fibrillation 18%
25. Atrial Remodeling 18%
26. Brain Natriuretic Peptide 16%
27. Pulmonary Embolism 16%
28. Sodium-Glucose Transport Proteins 16%
29. Hypoglycemia 16%
30. Transplants 15%
31. Dilatation 15%
32. Messenger RNA 14%
33. Confidence Intervals 14%
34. Electroencephalography 14%
35. Therapeutics 13%
36. Primary Health Care 13%
37. Angiotensin Receptors 13%
38. Myocardial Perfusion Imaging 13%
39. Blood Pressure 13%
40. copeptins 13%
41. Perfusion Imaging 12%
42. Biosensing Techniques 12%
43. Mortality 12%
44. Neprilysin 12%
45. Protein-Lysine 6-Oxidase 12%
46. Blood Vessels 11%
47. Isosorbide Dinitrate 11%
48. Leukocyte L1 Antigen Complex 11%
49. Electrocardiography 11%
50. Diuretics 11%